Shengke Pharmaceuticals (Jiangsu) Ltd.
PrivateLast Round
Early Funding
Nov 28, 2023
Company Overview
Shengke Pharmaceuticals (Jiangsu) Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was an Early Funding round in November 2023.
Shengke Pharmaceuticals (Jiangsu) Ltd. is a biopharmaceutical company focused on the discovery and development of targeted small molecule inhibitors for the treatment of cancer and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shengke Pharmaceuticals (Jiangsu) Ltd. Comparables
Compare Shengke Pharmaceuticals (Jiangsu) Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eilean Therapeutics | 80% | |
| Binjiang Pharma, Inc. | 79% | |
| Relay Therapeutics | 69% |
For institutional investors. Book with your work email.
Shengke Pharmaceuticals (Jiangsu) Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Nov 28, 2023 | ||||
| Early Funding | Jul 9, 2020 | ||||
| Angel | Apr 20, 2019 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 76% MoM.
- Nov 28, 2023
Secured funding from Suzhou New District Sci-Tech Angel Fund.
For institutional investors. Book with your work email.
Shengke Pharmaceuticals (Jiangsu) Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Shengke Pharmaceuticals (Jiangsu) Ltd.'s valuation, stock price, and market status.
Is Shengke Pharmaceuticals (Jiangsu) Ltd. a public or private company?
Shengke Pharmaceuticals (Jiangsu) Ltd. is a private company.
What is the current stock price of Shengke Pharmaceuticals (Jiangsu) Ltd.?
Shengke Pharmaceuticals (Jiangsu) Ltd. is a private company, so its shares have no public market price. Caplight tracks Shengke Pharmaceuticals (Jiangsu) Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Shengke Pharmaceuticals (Jiangsu) Ltd. worth (valuation)?
Valuation information for Shengke Pharmaceuticals (Jiangsu) Ltd. is not publicly available.
Can I buy Shengke Pharmaceuticals (Jiangsu) Ltd. stock?
Shengke Pharmaceuticals (Jiangsu) Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Shengke Pharmaceuticals (Jiangsu) Ltd.'s last funding round?
Shengke Pharmaceuticals (Jiangsu) Ltd.'s most recent funding round was Early Funding on November 28, 2023.
Who are the main investors in Shengke Pharmaceuticals (Jiangsu) Ltd.?
Investor information for Shengke Pharmaceuticals (Jiangsu) Ltd. is not publicly disclosed.
Will Shengke Pharmaceuticals (Jiangsu) Ltd. IPO soon?
No public IPO plans have been announced for Shengke Pharmaceuticals (Jiangsu) Ltd..
How can I track Shengke Pharmaceuticals (Jiangsu) Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Shengke Pharmaceuticals (Jiangsu) Ltd.'s shares on secondary markets.